The effects of cholesterol-lowering drugs on neurocognitive function: systematic review and meta analysis.

Li K, Li Y, Jiang X, Zhu Y

Open source

DOI: 10.3389/fneur.2026.1696228
Published: 2026
Container: Frontiers in neurology
Publisher: Not recorded
Open access: yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
supportingDirectory of Open Access Journals: A matching record was returned by DOAJ. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.3389/fneur.2026.1696228,
  title = {The effects of cholesterol-lowering drugs on neurocognitive function: systematic review and meta analysis.},
  author = {Li K and Li Y and Jiang X and Zhu Y},
  year = {2026},
  journal = {Frontiers in neurology},
  doi = {10.3389/fneur.2026.1696228},
  url = {https://doi.org/10.3389/fneur.2026.1696228}
}

RIS

TY  - JOUR
TI  - The effects of cholesterol-lowering drugs on neurocognitive function: systematic review and meta analysis.
AU  - Li K
AU  - Li Y
AU  - Jiang X
AU  - Zhu Y
PY  - 2026
JO  - Frontiers in neurology
DO  - 10.3389/fneur.2026.1696228
UR  - https://doi.org/10.3389/fneur.2026.1696228
ER  -

APA

K, L., Y, L., X, J., & Y, Z. (2026). The effects of cholesterol-lowering drugs on neurocognitive function: systematic review and meta analysis.. Frontiers in neurology. https://doi.org/10.3389/fneur.2026.1696228

Source records

pubmed · retrieved 2026-09-25T12:14:00.529Z
europe-pmc · retrieved 2026-09-25T12:14:00.531Z
doaj · retrieved 2026-09-25T12:14:00.535Z